These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 4736825)

  • 1. Phytohaemagglutinin-induced cytotoxic effector lymphocyte function in patients with the Wiskott-Aldrich syndrome (WAS).
    Sherwood G; Blaese RM
    Clin Exp Immunol; 1973 Apr; 13(4):515-20. PubMed ID: 4736825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormalities of chemotactic lymphokine synthesis and mononuclear leukocyte chemotaxis in Wiskott-Aldrich syndrome.
    Altman LC; Snyderman R; Blaese RM
    J Clin Invest; 1974 Aug; 54(2):486-93. PubMed ID: 4136226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunodeficiency in the Wiskott-Aldrich syndrome.
    Blaese RM; Strober W; Waldmann TA
    Birth Defects Orig Artic Ser; 1975; 11(1):250-4. PubMed ID: 238675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective lymphocyte transformation and delayed hypersensitivity in Wiskott-Aldrich syndrome.
    Oppenheim JJ; Blaese RM; Waldmann TA
    J Immunol; 1970 Apr; 104(4):835-44. PubMed ID: 4986478
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro cytotoxicity of lymphocytes from patients with "acquired" and sex-linked agammaglobulinaemia.
    Lieber E; Douglas SD; Fudenberg HH
    Clin Exp Immunol; 1971 Nov; 9(5):603-9. PubMed ID: 5169336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte-mediated cytotoxicity induced by humoral antibodies. Mechanism of induction and surface markers of the effector cells.
    Perlmann P; Perlmann H; Müller-Eberhard HJ
    Int Arch Allergy Appl Immunol; 1973; 45(1):278-80. PubMed ID: 4542233
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro studies of lymphocytes from patients with plasma cell myeloma. I. Stimulation by mitogens and cytotoxic activities.
    Mellstedt H; Holm G
    Clin Exp Immunol; 1973 Nov; 15(3):309-20. PubMed ID: 4764348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The detection and identification of subpopulations of circulating human lymphocytes, monocytes and neutrophils capable of effecting a mitogen-induced cell-mediated cytotoxic reaction towards erythrocytes of various species.
    Cortens M; Sklar S; Richter M
    Immunology; 1980 Nov; 41(3):623-34. PubMed ID: 7461704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The stimulation and inhibition of nonimmune lymphocyte-mediated cytotoxicity in vitro.
    Shivers BR; Forbes JT; Cruse JM; Gillespie GY; Hester RB
    J Reticuloendothel Soc; 1972 Sep; 12(3):257-82. PubMed ID: 5074439
    [No Abstract]   [Full Text] [Related]  

  • 10. The in vitro response of peripheral blood lymphocytes from patients with Wiskott-Aldrich syndrome.
    Marinkovich VA
    Clin Allergy; 1972 Mar; 2(1):69-78. PubMed ID: 4275189
    [No Abstract]   [Full Text] [Related]  

  • 11. Disorders of regulatory T cell function in patients with the Wiskott-Aldrich syndrome.
    Zabay JM; Fontán G; Campos A; García-Rodriguez MC; Pascual-Salcedo D; Bootello A; de la Concha EG
    Clin Exp Immunol; 1984 Apr; 56(1):23-8. PubMed ID: 6609033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro lymphocyte response in some immunity deficiency diseases and in intrauterine virus infections.
    Marshall WC; Cope WA; Soothill JF; Dudgeon JA
    Proc R Soc Med; 1970 Apr; 63(4):351-4. PubMed ID: 4315114
    [No Abstract]   [Full Text] [Related]  

  • 13. [Transfer factor and thymosin in the treatment of Wiskott-Aldrich syndrome].
    Franchi F; Segni G; Stabile A; Ammirati P; Aiuti F
    Minerva Pediatr; 1978 Apr; 30(8):609-13. PubMed ID: 661768
    [No Abstract]   [Full Text] [Related]  

  • 14. Diminished in vitro toxic effect of phytohaemagglutinin for lymphocytes of rats bearing syngeneic tumours.
    Medzihradský J; Babusíková O; Koníková E
    Neoplasma; 1973; 20(4):353-61. PubMed ID: 4147074
    [No Abstract]   [Full Text] [Related]  

  • 15. Low level immunoglobulin production by mitogenically stimulated rabbit lymphocytes.
    Itatani CA; Fung HC
    J Reticuloendothel Soc; 1974 Mar; 15(3):171-84. PubMed ID: 4838129
    [No Abstract]   [Full Text] [Related]  

  • 16. [Some immunohematological aspects of 2 cases of the Wiskott-Aldrich syndrome].
    Ferrara M; Ponte G; Esposito L
    Pediatria (Napoli); 1983; 91(1):75-80. PubMed ID: 6604260
    [No Abstract]   [Full Text] [Related]  

  • 17. Specifically cytotoxic lymphocytes produced by preincubation with antibody-complexed target cells.
    Perlmann P; Perlmann H; Biberfeld P
    J Immunol; 1972 Feb; 108(2):558-61. PubMed ID: 5049099
    [No Abstract]   [Full Text] [Related]  

  • 18. Cytotoxic lymphocytes in Hashimoto thyroiditis. An in vitro assay system using 51 Cr-labelled chicken red blood cells coated with thyroglobulin.
    Calder BA; Penhale WJ; Barnes EW; Irvine WJ
    Clin Exp Immunol; 1973 May; 14(1):19-23. PubMed ID: 4740396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A diagnostic assay for the Wiskott-Aldrich syndrome and its variant forms.
    Siminovitch KA; Greer WL; Novogrodsky A; Axelsson B; Somani AK; Peacocke M
    J Investig Med; 1995 Apr; 43(2):159-69. PubMed ID: 7735919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specificity of destruction by lymphocytes activated in mixed leukocyte culture.
    Lightbody JJ; Bach FH
    Transplant Proc; 1972 Sep; 4(3):307-10. PubMed ID: 4263510
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.